Jiangsu, China

Qi Wu

This inventor holds 1 USPTO granted patent. Top assignees: Jiangsu Hengrui Medicine Company Ltd., Shanghai Hengrui Pharmaceutical Co., Ltd.. Active years: 2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Qi Wu. Retrieved from https://idiyas.com/inventor/qi-wu-g65wz4og

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 8.0

ph-index = 1


Company Filing History:


Years Active: 2025

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Qi Wu - Innovator in Pyridopyrimidine Derivatives

Introduction

Qi Wu is a notable inventor based in Jiangsu, China. He has made significant contributions to the field of pharmaceuticals, particularly through his innovative work on pyridopyrimidine derivatives. His research focuses on improving the physical and chemical properties of these compounds, which can facilitate clinical treatments.

Latest Patents

Qi Wu holds 1 patent for his invention titled "Crystal form of pyridopyrimidine derivative and preparation method thereof." This patent relates to a specific crystal form of a pyridopyrimidine derivative and outlines a preparation method for it. The new crystal form exhibits enhanced physical and chemical properties, making it a valuable asset in clinical applications.

Career Highlights

Throughout his career, Qi Wu has worked with prominent companies in the pharmaceutical industry. He has been associated with Jiangsu Hengrui Medicine Company Ltd. and Shanghai Hengrui Pharmaceutical Co., Ltd. His work in these organizations has contributed to advancements in drug development and formulation.

Collaborations

Qi Wu has collaborated with several professionals in his field, including Zhenxing Du and Jie Wang. These collaborations have likely enriched his research and contributed to the successful development of his patented inventions.

Conclusion

Qi Wu's innovative work in the field of pyridopyrimidine derivatives showcases his commitment to advancing pharmaceutical science. His contributions are expected to have a lasting impact on clinical treatments and drug development.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…